Publication | Closed Access

Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial

ThrombosisVenous ThrombosisThromboembolic ComplicationsCardiovascular DiseaseSuperficial-vein ThrombosisPatient SafetyVascular SurgeryPharmacotherapySurgeryMedicineAnticoagulant